Open AccessEffectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients
Author(s) -
Kai Zhang,
Xiangyang Sun,
Fubo Xie,
Wencheng Jian,
Caixia Li
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1175_16
Subject(s) - sorafenib , medicine , hepatocellular carcinoma , response evaluation criteria in solid tumors , adverse effect , progressive disease , gastroenterology , side effect (computer science) , diarrhea , liver function , surgery , chemotherapy , computer science , programming language
The aim is to study the effectiveness and side effects of sorafenib administration after transarterial chemoembolization (TACE) in advanced hepatocellular carcinoma (HCC) patients. To evaluate the safety of the combination of sorafenib and TACE to treat HCC.